Research on quaternary ammonium compounds (QACs) and their effectiveness against MRSA has shown promising results. Studies have found that QACs have strong antimicrobial properties, making them effective in combating MRSA infections. Various methodologies, including in vitro and in vivo experiments, have been used to test the efficacy of QACs against MRSA. The findings suggest that QACs can effectively kill MRSA bacteria and prevent their spread. This research has significant implications for the development of new treatments for MRSA infections, as QACs could potentially be used as a viable alternative to traditional antibiotics. Further research is needed to fully understand the mechanisms behind QACs' effectiveness and to optimize their use in clinical settings.